stella
beta
Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC — Stella
Recruiting
Back to Extensive-stage Small-cell Lung Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(5 sites)
Germany
University Hospital Augsburg, Radiation Oncology, Augsburg, Bavaria
University Hospital Erlangen, Radiation Oncology, Erlangen, Bavaria
University Hospital Regensburg, Clinic and Polyclinic for Radiotherapy, Regensburg, Bavaria
Kliniken Maria Hilf, Mönchengladbach, North Rhine-Westphalia
Saarland University Medical Center and Saarland University Faculty of Medicine, Clinic for Radiotherapy and Radiooncology, Homburg, Saarland
View full record on ClinicalTrials.gov